This section should include the following:
• Time line for the trials (include a diagram)
• Brief description of the experimental design including the method of randomization, the extent of the blinding and the method(s) to be employed to ensure the blinding is sustained throughout the course of the trials
• Method of treatment assignment
• Rules governing early termination or modification of the protocol.
Was this article helpful?